Establishing Mobile Transcranial Magnetic Stimulation
Recruiting · NCT06748209 · Interventional (participants receive a specific treatment) · Lead sponsor: Medical University of South Carolina
View the official record on ClinicalTrials.gov →Interventions studied
FDA cleared TMS for treating depressionLeft prefrontal Transcranial Magnetic Stimulation (TMS)
What this trial is about
In this pilot study, investigators propose to design and create a portable TMS unit, in a van, and then test out delivering TMS in three different locations in South Carolina, all affiliated with MUSC and within 2-hours driving from Charleston, SC. This study would test out this new delivery mode, and provide valuable feasibility, safety, and efficacy lessons for later refinement and potential widespread adoption of mobile TMS as a treatment option, both in our state and across the US.
Who can take part
Age range
22 Years to 80 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 4
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Adult (22-80 years old)
- Have treatment-resistant depression as defined by the e-Mini, and the antidepressant treatment history form (ATHF short).
- Be able to read and communicate in English.
- Able to provide their own consent.
- Access to a computer with videoconferencing ability for initial consent and telescreen.
Exclusion criteria
- Patients with unstable medical conditions that might make TMS unsafe. This includes current poorly controlled seizures.
- Ferromagnetic metal in the head.
- Pregnant.
- Currently active substance abuse except tobacco.
Where it is running
2 locations listed across 1 US state.
- Medical Univerity of South Carolina - Charleston, South Carolina, United States
- Medical Univerity of South Carolina - Charleston, South Carolina, United States